U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H24F3N3O2
Molecular Weight 431.4508
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MK-0249

SMILES

CC1=NC2=C(C(=O)N1C3=CC=C(OCCCN4CCCC4)C=C3)C(=CC=C2)C(F)(F)F

InChI

InChIKey=DDDZBLNULGDPGA-UHFFFAOYSA-N
InChI=1S/C23H24F3N3O2/c1-16-27-20-7-4-6-19(23(24,25)26)21(20)22(30)29(16)17-8-10-18(11-9-17)31-15-5-14-28-12-2-3-13-28/h4,6-11H,2-3,5,12-15H2,1H3

HIDE SMILES / InChI

Molecular Formula C23H24F3N3O2
Molecular Weight 431.4508
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

MK-0249 is a potent H3 receptor inverse agonist patented by Abbott Laboratories for treatment of cognitive deficits. MK-0249 demonstrates promising results in preclinical models of cognitive disorders. MK0249 has been used in trials studying the treatment of Hypopnea Syndrome, Alzheimer's Disease, Paranoid Schizophrenia ets. Unfortunately, MK-0249 failed to demonstrate efficacy in schizophrenia, mild-to-moderate Alzheimer's Disease, attention-deficit/hyperactivity disorder, and future development has been discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD.
2012 May
(11)C-MK-8278 PET as a tool for pharmacodynamic brain occupancy of histamine 3 receptor inverse agonists.
2014 Jan
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.
2015 Jul
Patents

Patents

Sample Use Guides

10mg once daily
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 07:48:57 GMT 2023
Edited
by admin
on Sat Dec 16 07:48:57 GMT 2023
Record UNII
KF50235Q04
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MK-0249
Common Name English
2-METHYL-3-(4-(3-PYRROLIDIN-1-YLPROPOXY)PHENYL)-5-(TRIFLUOROMETHYL)QUINAZOLIN-4-ONE
Systematic Name English
MK0249
Code English
Code System Code Type Description
FDA UNII
KF50235Q04
Created by admin on Sat Dec 16 07:48:57 GMT 2023 , Edited by admin on Sat Dec 16 07:48:57 GMT 2023
PRIMARY
PUBCHEM
11697697
Created by admin on Sat Dec 16 07:48:57 GMT 2023 , Edited by admin on Sat Dec 16 07:48:57 GMT 2023
PRIMARY
ChEMBL
CHEMBL476323
Created by admin on Sat Dec 16 07:48:57 GMT 2023 , Edited by admin on Sat Dec 16 07:48:57 GMT 2023
PRIMARY
EPA CompTox
DTXSID70151492
Created by admin on Sat Dec 16 07:48:57 GMT 2023 , Edited by admin on Sat Dec 16 07:48:57 GMT 2023
PRIMARY
CAS
1167574-41-5
Created by admin on Sat Dec 16 07:48:57 GMT 2023 , Edited by admin on Sat Dec 16 07:48:57 GMT 2023
PRIMARY
SMS_ID
300000041404
Created by admin on Sat Dec 16 07:48:57 GMT 2023 , Edited by admin on Sat Dec 16 07:48:57 GMT 2023
PRIMARY
DRUG BANK
DB11910
Created by admin on Sat Dec 16 07:48:57 GMT 2023 , Edited by admin on Sat Dec 16 07:48:57 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY